Literature DB >> 21669397

The TRIM family protein KAP1 inhibits HIV-1 integration.

Awatef Allouch1, Cristina Di Primio, Emanuele Alpi, Marina Lusic, Daniele Arosio, Mauro Giacca, Anna Cereseto.   

Abstract

The integration of viral cDNA into the host genome is a critical step in the life cycle of HIV-1. This step is catalyzed by integrase (IN), a viral enzyme that is positively regulated by acetylation via the cellular histone acetyl transferase (HAT) p300. To investigate the relevance of IN acetylation, we searched for cellular proteins that selectively bind acetylated IN and identified KAP1, a protein belonging to the TRIM family of antiviral proteins. KAP1 binds acetylated IN and induces its deacetylation through the formation of a protein complex which includes the deacetylase HDAC1. Modulation of intracellular KAP1 levels in different cell types including T cells, the primary HIV-1 target, revealed that KAP1 curtails viral infectivity by selectively affecting HIV-1 integration. This study identifies KAP1 as a cellular factor restricting HIV-1 infection and underscores the relevance of IN acetylation as a crucial step in the viral infectious cycle.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669397     DOI: 10.1016/j.chom.2011.05.004

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  62 in total

1.  Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.

Authors:  Xiang Li; Yasuhiro Koh; Alan Engelman
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 2.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

3.  Gypsy and the birth of the SCAN domain.

Authors:  Ryan O Emerson; James H Thomas
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

Review 4.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

5.  MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA.

Authors:  William M Schneider; Dai-tze Wu; Vaibhav Amin; Sriram Aiyer; Monica J Roth
Journal:  Virology       Date:  2012-02-23       Impact factor: 3.616

6.  Allosteric HIV Integrase Inhibitors Promote Formation of Inactive Branched Polymers via Homomeric Carboxy-Terminal Domain Interactions.

Authors:  Kushol Gupta; Audrey Allen; Carolina Giraldo; Grant Eilers; Robert Sharp; Young Hwang; Hemma Murali; Katrina Cruz; Paul Janmey; Frederic Bushman; Gregory D Van Duyne
Journal:  Structure       Date:  2020-12-23       Impact factor: 5.006

7.  KAP-1 promotes resection of broken DNA ends not protected by γ-H2AX and 53BP1 in G₁-phase lymphocytes.

Authors:  Anthony T Tubbs; Yair Dorsett; Elizabeth Chan; Beth Helmink; Baeck-Seung Lee; Putzer Hung; Rosmy George; Andrea L Bredemeyer; Anuradha Mittal; Rohit V Pappu; Dipanjan Chowdhury; Nima Mosammaparast; Michael S Krangel; Barry P Sleckman
Journal:  Mol Cell Biol       Date:  2014-05-19       Impact factor: 4.272

8.  RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction.

Authors:  Kelly M Marno; Eithne O'Sullivan; Christopher E Jones; Julieta Díaz-Delfín; Claire Pardieu; Richard D Sloan; Áine McKnight
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

Review 9.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

10.  Poly(ADP-ribose) polymerase 1 promotes transcriptional repression of integrated retroviruses.

Authors:  Murilo T D Bueno; Daniel Reyes; Luis Valdes; Adarsh Saheba; Eduardo Urias; Crystal Mendoza; Oliver I Fregoso; Manuel Llano
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.